Pulse.

a daily field guide to health research that matters

◆ Console

‹ Wed · 28 Oct 2026
Standard addition

Cardiovascular Effects of GLP-1 Receptor Agonists Across Age Groups: An Updated Meta-Analysis of Randomized Controlled Trials.

GLP-1 drugs appear to work similarly well for heart protection across different age groups, including people over 75.

This systematic review and meta-analysis evaluated Cardiovascular Effects of GLP-1 Receptor Agonists Across Age Groups: An Updated Meta-Analysis of Randomized Controlled Trials. The abstract reports Among trials reporting three age strata, RHRs showed no clear evidence of effect modification for 65 to < 75 or ≥ 75 years versus < 65 years, but data were available from only four trials, and the ≥ 75-year group was relatively small.

What the study was

Study design
Systematic review and meta-analysis
Population
Human participants or patients described in the PubMed abstract
Category
Public Health
Maturity
Validated
Journal
Diabetes Obes Metab

Why it surfaced

Systematic review and meta-analysis; PubMed abstract reviewed; synthesis was scored conservatively and no evidence-dependent priority flag was applied.

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.